Exendin 4 polypeptide fragments and use thereof

Details for Australian Patent Application No. 2006264162 (hide)

Owner Changzhou Pharmaceutical Factory Co., Ltd.

Inventors Ma, Xiaopeng; Xi, Shaoqi; Wang, Bing

Agent Collison & Co

Pub. Number AU-A-2006264162

PCT Pub. Number WO2007/000118

Priority 200510040823.8 29.06.05 CN

Filing date 29 June 2006

Wipo publication date 4 January 2007

International Classifications

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

14 February 2008 PCT application entered the National Phase

  PCT publication WO2007/000118 Priority application(s): WO2007/000118

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006264170-Pyrazolo[3,4-b]pyridin-2-yl)-benzoic acid derivatives as HIV integrase inhibitors

2006264156-Method for producing hot water utilizing combined heat resources of solar energy and heat pump in the manner of heating water at multiple stages and accumulating energy and a device especially for carrying out the method